LabCorp's latest deal hones in on digital clinical trials for drug development
Mobi Health News
MAY 28, 2020
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Mobi Health News
MAY 28, 2020
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
Mobi Health News
OCTOBER 4, 2022
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mobi Health News
JANUARY 31, 2023
Cough monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.
Mobi Health News
MARCH 2, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
Mobi Health News
NOVEMBER 19, 2024
The company will use the funds to support people who are managing rare and complex conditions.
Mobi Health News
OCTOBER 1, 2020
Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.
Mobi Health News
JULY 9, 2019
From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.
Mobi Health News
JULY 10, 2019
Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.
KevinMD
MARCH 14, 2019
An important part of advancing medical research and drug development is making participation in clinical trials easier and more inclusive. To develop treatments that work on men, women, and children of all ages and different ethnicities we need to have clinical trial data that represents our diverse population.
FierceHealthIT
DECEMBER 11, 2020
Optum: Why COVID-19 could significantly change the drug development pipeline. Fri, 12/11/2020 - 12:12.
Mobi Health News
DECEMBER 28, 2022
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Mobi Health News
MAY 19, 2022
They aim to bring down the period and costs for new drug development.
Mobi Health News
APRIL 5, 2022
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
FierceHealthIT
JULY 11, 2019
Startup Medicare Advantage insurer Clover Health has launched a new drug development subsidiary called Clover Therapeutics.
Electronic Health Reporter
NOVEMBER 18, 2024
One of the most prominent trends shaping this industry is the outsourcing of various stages of drug development. As companies […] The article Outsourcing In Drug Development: A Key Strategy for Sustainable Growth appeared first on electronichealthreporter.com.
Digital Health Global
MARCH 28, 2024
Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.
FierceHealthIT
MAY 3, 2021
Optum: Why payers should be watching flurry of drug development activity around eczema. Mon, 05/03/2021 - 15:53.
Mobi Health News
FEBRUARY 19, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.
FierceHealthIT
JANUARY 20, 2022
Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development. Thu, 01/20/2022 - 17:06.
Healthcare IT Today
JANUARY 23, 2024
Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D.,
Mobi Health News
JULY 15, 2021
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
FierceHealthIT
AUGUST 12, 2024
Consumer genetic testing company 23andMe sees an opportunity to get in on the weight loss boom. 23andMe plans to launch a GLP-1 weight loss telehealth membership through its Lemonaid Health platform by the end of the month.
Digital Health Global
JANUARY 10, 2024
As we look forward to an exhilarating 2024, we believe this partnership will pave the way for significant advancements in the field of drug R&D for the benefit of the patients,” explained Khai Pham, CEO of ThinkingNodeLife.ai Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.
Mobi Health News
APRIL 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States. Existing backer Woodford Investment Management also participated in the round, which brings the company’s total funds raised to over $200 million.
Digital Health Global
JANUARY 26, 2024
Under the program, Deliberate AI’s assessment tool for anxiety and depression, the AI-generated Clinical Outcome Assessment or AI-COA , will receive support to become a qualified drug development tool (DDT). Global experts have also expressed support for Deliberate AI’s innovative approach.
ActiGraph
SEPTEMBER 3, 2024
The field of drug development is no exception. In this blog post, we'll explore the history of AI, clarify key concepts and common questions, and delve into its use in drug development.
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
Digital Health Global
SEPTEMBER 19, 2023
Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.
Healthcare IT Today
APRIL 14, 2022
Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drug development and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].
Healthcare IT Today
NOVEMBER 24, 2021
The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?
Healthcare IT Today
APRIL 25, 2024
In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.
Digital Health Global
FEBRUARY 19, 2024
This expansion mirrors a trend identified in an industry report jointly published by Biofourmis and HealthXL last year, predicting widespread adoption of digital endpoints by pharmaceutical companies in drug development programs by 2030.
Healthcare IT Today
MAY 25, 2021
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.
Digital Health Global
MARCH 30, 2023
The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. Drug development process questions the reliability and accuracy of DHT products.
Electronic Health Reporter
APRIL 8, 2022
Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drug developed, pass clinical trials and ultimately approved by […]. The article How Technology Is Improving Success Rates In Drug Clinical Trials appeared first on electronichealthreporter.com.
Digital Health Global
MARCH 29, 2023
With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We
Health Populi
APRIL 29, 2019
In the past couple of months, Amazon announced many health-related plans and developments, including: Accepting medical and health savings accounts (HSAs) to pay for consumer health products like over-the-counter drugs.
ActiGraph
APRIL 17, 2024
The Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) Nocturnal Scratch working group was launched in November 2023, with the goal of bringing to the market a fit-for-purpose digital measure of nocturnal scratch.
ActiGraph
JUNE 21, 2024
The need to transform the clinical trial process to deliver more effective treatments to patients faster is greater than ever, and a key part of this transformation is a focus on putting the patient first.
ActiGraph
OCTOBER 31, 2024
Digital health technologies (DHT) can collect objective, multi-dimensional data passively and remotely with a limited burden for clinical trial participants, providing a way to capture previously inaccessible insights to support drug development and commercialization.
hea!thcare innovation - Clinical IT
MAY 16, 2019
Real-world evidence has the potential to be especially valuable in a number of healthcare use cases
FierceHealthIT
MARCH 22, 2018
The study’s authors urge policymakers to support the development of new strategies to prevent infections and to support innovative antibiotic drug development. Multiply that by the estimated number of antibiotic-resistant infections, and costs run well over $2 billion per year.
Healthcare IT Today
MARCH 1, 2024
In this video, he describes other ways that AI can make drug development more efficient. At the design stage, a drug company can run millions of simulations to determine where risks lie and what parameters are most promising.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content